V.R. Deangelis M.D.P.C. v. Comm'r , 94 T.C.M. 526 ( 2007 )


Menu:
  •                         T.C. Memo. 2007-360
    UNITED STATES TAX COURT
    V.R. DEANGELIS M.D.P.C. & R.T. DOMINGO M.D.P.C., V.R. DEANGELIS
    M.D.P.C., TAX MATTERS PARTNER, ET AL.,1 Petitioners v.
    COMMISSIONER OF INTERNAL REVENUE, Respondent
    Docket Nos.   10634-05, 10635-05,   Filed December 5, 2007.
    10636-05, 10637-05,
    10638-05.
    1
    Cases of the following petitioners are consolidated
    herewith: Vincent and Jeanette DeAngelis (collectively,
    DeAngelises), docket No. 10635-05; Rodolfo and Bernadette Domingo
    (collectively, Domingos), docket No. 10636-05; Keith and Kathleen
    Durante (collectively, Durantes), docket No. 10637-05, and
    Anthony J. and Mary Ann Capizzi (collectively, Capizzis), docket
    No. 10638-05. While the parties sometimes refer to the name
    “DeAngelis” as “De Angelis”, we consistently refer to that name
    as “DeAngelis”. We also note that the first word in the name of
    each relevant professional corporation is a complete word but
    that the parties sometimes refer to the word by its initial
    letter. With the exception of the caption and of the
    partnership, V.R. DeAngelis M.D.P.C. & R.T. Domingo M.D.P.C.,
    whose name is actually spelled using only the initial letter of
    the first word of each professional corporation referenced
    therein, we refer to each professional corporation by using its
    full first word.
    - 2 -
    John T. Morin and Ira B. Stechel, for petitioners.
    Peter James Gavagan, Peggy J. Gartenbaum, and Thomas A.
    Dombrowski, for respondent.
    MEMORANDUM FINDINGS OF FACT AND OPINION
    LARO, Judge:   These cases are consolidated for purposes of
    trial, briefing, and opinion.   Each couple consists of a medical
    doctor and his wife, and each doctor is the sole owner of an S
    corporation that was a partner in the partnership V.R. DeAngelis
    M.D.P.C. & R.T. Domingo M.D.P.C. (VRD/RTD).   These cases concern
    amounts paid in 1993 and 1994 by the S corporations to VRD/RTD
    and its ensuing contributions of those amounts to the Severance
    Trust Executive Program Multiple Employer Supplemental Benefit
    Plan and Trust (STEP), a plan that was promoted to wealthy
    professionals as a welfare benefits fund that was part of a 10-
    or-more-employer plan described in section 419A(f)(6).2   STEP
    used the contributions to purchase and pay the premiums on six
    whole life insurance policies, five of which were each written
    with respect to one or both spouses of each couple (with the
    2
    Unless otherwise indicated, section references are to the
    applicable versions of the Internal Revenue Code, Rule references
    are to the Tax Court Rules of Practice and Procedure, and dollar
    amounts are rounded to the dollar. We use the term “plan” for
    convenience and do not suggest that any part of the STEP plan is
    a bona fide plan for Federal income tax purposes.
    - 3 -
    exception of the Capizzis, who had no policy insuring either of
    their lives) and were each payable to the beneficiaries of the
    insured’s choosing in the event of the insured’s death.    The
    sixth life insurance policy was written on the life of Kerry
    Quinn (Ms. Quinn), an employee of VRD/RTD who was its office
    manager.
    For each subject year, respondent determined in the notice
    of final partnership administrative adjustment (FPAA) that
    VRD/RTD could not deduct the $585,000 it paid in that year to
    STEP as contributions to a welfare benefits fund.   The FPAA
    stated in part that the payments were not ordinary and necessary
    business expenses under section 162(a).
    Respondent determined in the notices of deficiency that the
    individual petitioners had the following deficiencies in their
    1993 and 1994 Federal income taxes:
    Individual Petitioners      1993         1994
    DeAngelises         $246,768    $208,447
    Domingos             185,422     184,932
    Durantes              29,174      42,020
    Capizzis               1,957       1,546
    The deficiencies generally are based on two determinations.
    First, respondent determined that the payments that the S
    corporations made to VRD/RTD for contribution to the STEP plan
    were not deductible by the S corporations because they were not
    ordinary and necessary business expenses under section 162(a).
    Respondent accordingly increased the net amount of passthrough
    - 4 -
    income received by each doctor from his S corporation.    Second,
    respondent determined that each doctor received income under
    section 61(a) in the amount of the life insurance premiums that
    were paid by his S corporation on his behalf.
    We decide whether the S corporations and VRD/RTD were
    entitled to deduct the payments related to the STEP plan as
    ordinary and necessary business expenses under section 162(a).
    We hold they were not to the extent that the payments related to
    the life insurance written on a life of someone other than Ms.
    Quinn.3   We also decide whether each doctor realized income in
    the amount of the life insurance premiums that were paid by his S
    corporation on his behalf.   We hold he did not.
    FINDINGS OF FACT
    I.   Preliminaries
    Some facts were stipulated.   The stipulated facts and the
    exhibits submitted therewith are incorporated herein by this
    reference.   We find the stipulated facts accordingly.   VRD/RTD
    had a legal address in the State of New York when its petition
    was filed.   The individual petitioners resided in the State of
    New York when their petitions were filed.
    3
    We understand respondent to have conceded that the
    payments are deductible to the extent they relate to the
    insurance written on the life of Ms. Quinn.
    - 5 -
    II.   Individual Petitioners
    A.     Overview
    Petitioner doctors are Vincent DeAngelis (Dr. DeAngelis),
    Rodolfo Domingo (Dr. Domingo), Keith Durante (Dr. Durante), and
    Anthony J. Capizzi (Dr. Capizzi) (collectively, doctors).     During
    1993 and 1994, each doctor wholly owned an S corporation that
    employed the doctor to provide his medical and surgical services
    for VRD/RTD.      Each S corporation was a professional corporation
    (PC), the sole employee of which was its owner.     The names of the
    PCs of Drs. DeAngelis, Domingo, Durante, and Capizzi were Vincent
    R. DeAngelis M.D.P.C., Rodolfo T. Domingo M.D.P.C., Keith Durante
    M.D.P.C., and Anthony J. Capizzi M.D.P.C., respectively.
    Each doctor and his wife filed a joint Form 1040, U.S.
    Individual Income Tax Return, for each of the years 1993 and
    1994.      Each couple’s returns reported compensation received from
    the doctor’s PC during those years.4
    4
    We use the term “compensation” to refer to wages,
    salaries, and the like. Unlike petitioners, we do not consider
    the term “compensation” to include the doctors’ distributive
    shares of income from their PCs. See sec. 61(a)(1), (13)
    (distinguishing as separate items of gross income "Compensation
    for services, including fees, commissions, fringe benefits, and
    similar items" from "Distributive share of partnership gross
    income"); cf. Campbell v. Commissioner, 
    943 F.2d 815
    , 822 (8th
    Cir. 1991), affg. in part and revg. in part on other grounds T.C.
    Memo. 1990-162. Nor (as discussed below) does the STEP plan
    define the term “compensation” to include such distributive
    shares.
    - 6 -
    B.   Dr. DeAngelis
    During 1993, 1994, and 1995, Dr. DeAngelis’s PC reportedly
    paid Dr. DeAngelis compensation of $928,000, $581,000, and
    $60,000, respectively.    The DeAngelises’ corresponding Federal
    income tax returns included those amounts in gross income.    Dr.
    DeAngelis’s PC did not reportedly pay Dr. DeAngelis any
    compensation thereafter.
    C.   Dr. Domingo
    During 1993, 1994, 1995, and 1996, Dr. Domingo’s PC
    reportedly paid Dr. Domingo compensation of $753,000, $452,976,
    $485,843, and $62,000, respectively.    The Domingos’ corresponding
    Federal income tax returns included those amounts in gross
    income.   Dr. Domingo’s PC did not reportedly pay Dr. Domingo any
    compensation thereafter.
    D.   Dr. Durante
    During 1993, 1994, 1995, and 1996, Dr. Durante’s PC
    reportedly paid Dr. Durante compensation of $136,000, $240,000,
    $283,919, and $208,079, respectively.    The Durantes’
    corresponding Federal income tax returns included those amounts
    in gross income.   During 1998 through 2003, Dr. Durante’s PC
    reportedly paid Dr. Durante compensation of $289,398, $340,527,
    $258,393, $250,604, $258,208 and $240,000, respectively.    The
    Durantes’ corresponding Federal income tax returns included those
    amounts in gross income.    The record does not allow the Court to
    - 7 -
    find the amount of compensation (if any) that Dr. Durante’s PC
    reportedly paid Dr. Durante in 1997.
    E.   Dr. Capizzi
    During 1993 and 1994, Dr. Capizzi’s PC reportedly paid Dr.
    Capizzi compensation of $609,000 and $719,001, respectively.      The
    Capizzis’ corresponding Federal income tax returns included those
    amounts in gross income.     During 1996 through 2003, Dr. Capizzi’s
    PC reportedly paid Dr. Capizzi compensation of $336,240,
    $240,070, $272,043, $294,601, $293,331, $190,271, $194,130 and
    $148,423, respectively.     The Capizzis’ corresponding Federal
    income tax returns included those amounts in gross income.     The
    record does not allow the Court to find the amount of
    compensation (if any) that Dr. Capizzi’s PC reportedly paid Dr.
    Capizzi in 1995.
    III.    VRD/RTD
    A.   General Information
    VRD/RTD was formed as a partnership on July 1, 1982, under
    the laws of New York.     VRD/RTD provided medical and surgical
    services to its patients through the doctors and operated under
    the name “South Shore Surgical Specialists”.     VRD/RTD reported
    its income and expenses for Federal income tax purposes using the
    cash receipts and disbursements method.     VRD/RTD filed 1993 and
    1994 Forms 1065, U.S. Partnership Return of Income, for its
    taxable years ended December 31, 1993 and 1994, respectively.
    - 8 -
    B.    Partners and Employees
    During 1993 and 1994, the five partners of VRD/RTD were the
    four PCs of the doctors and a fifth PC owned by another doctor,
    Edgar Borrero (Dr. Borrero).    The senior partner of VRD/RTD was
    Vincent R. DeAngelis M.D.P.C.    The partners’ percentages of
    profits, losses, and ownership of capital for 1993 were as
    follows:
    Partner                Beginning of Year    End of Year
    Vincent R. De Angelis M.D.P.C.         35.09%              25%
    Rodolfo T. Domingo M.D.P.C             25.81               23
    Anthony J. Capizzi M.D.P.C.            20.58               24
    Edgar Borrero M.D.P.C.                 18.52               18
    Keith Durante M.D.P.C.1                    0               10
    1
    Keith Durante M.D.P.C. became a partner of VRD/RTD on or
    about July 1, 1993.
    The partners’ percentages of profits, losses, and ownership of
    capital for 1994 were as follows:
    Partner                Beginning of Year     End of Year
    Vincent R. De Angelis M.D.P.C          25%                 34%
    Rodolfo T. Domingo M.D.P.C.            23                  17
    Anthony J. Capizzi M.D.P.C.            24                  20
    Edgar Borrero M.D.P.C.                 18                  17
    Keith Durante M.D.P.C.                 10                  12
    During 1993 and 1994, VRD/RTD employed nurses, office staff,
    and an office manager (i.e., Ms. Quinn).       VRD/RTD had at least 29
    employees during 1993 and at least 34 employees during 1994.
    VRD/RTD did not directly pay the doctors any compensation during
    either subject year.
    - 9 -
    C.     Arrangements With PCs
    VRD/RTD entered into arrangements with the PCs for the
    provision of the doctors’ medical services.     The doctors
    performed their services for the patients of VRD/RTD, and VRD/RTD
    billed the patients for the fees due on these services.       VRD/RTD
    received payment of the fees, deposited the payments into its
    bank account, and reported the payments as income on its Forms
    1065.     Dr. Domingo performed services for VRD/RTD through the end
    of 1999; afterwards, through 2003, Dr. Domingo continued to work
    for his PC performing services for other than VRD/RTD.     Dr.
    DeAngelis terminated his services with VRD/RTD on or about
    December 31, 2003.
    D.     Partnership Agreement
    The VRD/RTD partnership agreement in effect for the subject
    years (partnership agreement) was executed on June 19, 1990.      The
    partnership agreement stated that Drs. DeAngelis and Domingo were
    employed by their PCs and that any future doctor who wished his
    PC to become a partner of VRD/RTD had to be employed by his PC.
    The partnership agreement stated that it was anticipated that Dr.
    DeAngelis would fully retire from VRD/RTD on July 1, 1994, and
    that Dr. Domingo would not retire until 1 year after Dr.
    DeAngelis retired.     If Dr. DeAngelis continued working for
    VRD/RTD until at least July 1, 1995, the partnership agreement
    allowed Dr. Domingo to retire at the same time as Dr. DeAngelis
    - 10 -
    or at any time after July 1, 1996.     The partnership agreement
    provided for payments to be made to a doctor’s PC in case the
    doctor became disabled.
    IV.   STEP
    A.     Overview
    STEP purports to provide eligible employees with severance
    benefits, funded entirely by their participating employer through
    the purchase of whole life insurance policies, and, if elected,
    an employer-provided optional life insurance benefit payable upon
    the death of a covered employee or an alternate insured.5    STEP
    invested the contributions made to the STEP plan in whole life
    insurance policies issued by eight insurance companies; namely,
    Metropolitan Life Insurance Co. (MetLife), Allmerica Financial
    Life Insurance and Annuity Co., National Life Insurance Co. of
    Vermont, Prudential Life Insurance Co. of America, Equitable Life
    Assurance Society of the United States, ITT Hartford Life
    Insurance Co., New York Life Insurance and Annuity Corp., and
    Massachusetts Mutual Life Insurance Co.     The life insurance
    policies insured the individuals covered by the STEP plan, and
    the STEP plan assets, as reported, consisted largely of the cash
    values of those policies.   Insurance agents earned substantial
    5
    An employee’s severance benefits were paid from the cash
    value of his or her whole life insurance policy.
    - 11 -
    commissions on the sales of the life insurance policies; e.g.,
    $605,053 in 1994.
    Drs. DeAngelis, Domingo, and Durante (collectively,
    participating doctors) participated in the STEP plan through
    their PCs and VRD/RTD.   Alvin Rapp (Mr. Rapp) was an authorized
    insurance agent of MetLife, and he recommended that all
    contributions to the STEP plan made on behalf of the
    participating doctors be invested in whole life insurance
    policies issued by MetLife.   That recommendation was followed.
    Each whole life insurance policy related to a participating
    doctor required that a payment be made annually on December 28
    for the policy year beginning on that date.
    B.   Formation of the STEP Plan
    The originator of the STEP concept was Kenneth L. Katz (Mr.
    Katz), an insurance agent credentialed as a chartered life
    underwriter and a chartered financial consultant.    In 1988, Mr.
    Katz asked his friend, Jeffrey Mamorsky (Mr. Mamorsky), to draft
    a plan that could be marketed as a tax-beneficial welfare
    benefits fund that complied with section 419A(f)(6).    Mr.
    Mamorsky was an attorney practicing primarily in the area of
    employee benefits and compensation.    Mr. Mamorsky later also
    served as counsel to the STEP plan; in that capacity, Mr.
    Mamorsky was available and willing to discuss with covered
    employees (at the expense of the STEP plan) the manner in which
    - 12 -
    they should prepare their applications for benefits from the
    plan.   The intent of the STEP plan was to create an incentive to
    buy, and thus to generate the sale of, whole life insurance
    policies through a claim of permissible tax avoidance and the
    ability to pay and deduct premiums on the purchased policies
    which would eventually be transferred to and owned by the
    insureds.    Many participants in the STEP plan believed that the
    plan was one of deferred compensation.
    Mr. Mamorsky prepared an initial version of the STEP plan on
    or about December 15, 1989, and Mr. Katz began operating the STEP
    plan at that time.    Mr. Mamorsky prepared a second version of the
    STEP plan in 1990.    Mr. Mamorsky wrote other and all versions of
    the STEP plan through June 2001, with an understanding that the
    deductibility of contributions was critical both to the
    marketability of the STEP plan and to the operation and existence
    of STEP.    The various versions of the STEP plan through June 2001
    included the following:
    Version   1:   Executed on December 15, 1989
    Version   2:   Version 1 Amended and Restated on July 26, 1990
    Version   3:   Executed on January 30, 1992
    Version   4:   Executed on December 29, 1993
    Version   5:   Executed as of November 1, 1994
    Version   6:   Executed as of February 14, 1997
    Version   7:   Executed as of June 11, 2001
    - 13 -
    The four versions executed in or after 1993 were stated as
    effective as of January 1, 1993.6
    C.   Trustees, Administrators, and Sponsors
    Connecticut National Bank was the STEP plan trustee from the
    plan’s inception through April 1, 1992.   The successor trustees
    were United States Trust Co. of New York (U.S. Trust), Mellon
    Trust of New York (Mellon Trust), and STEP Plan Services, Inc.
    (SPSI).   U.S. Trust served as trustee from April 1, 1992, through
    February 14, 1997; Mellon Trust served as trustee from
    February 14, 1997, through February 2002; and SPSI served as
    trustee from February 2002 to date.
    STEP, Inc., served as the STEP plan administrator from the
    plan’s inception through July 26, 1990.   Teplitzky & Co., L.L.C.
    (Teplitzky & Co.), acting primarily through its principal Jeffrey
    Teplitzky (Mr. Teplitzky), was the successor plan administrator
    from July 26, 1990, through February 7, 2002.   The current plan
    administrator is SPSI.   During the relevant time, Daniel E.
    Carpenter (Mr. Carpenter) had sole signatory authority on behalf
    of SPSI and served as its chairman.
    6
    There is also a 1992 version of the STEP plan for MetLife
    and, beginning in February 1997, separate plans and trusts for
    the eight insurance companies whose policies were sold through
    STEP. According to petitioners, the participating doctors were
    covered by version 3 when VRD/RTD adopted the STEP plan on or
    about Dec. 20, 1993, and were covered by version 4 as of Dec. 29,
    1993.
    - 14 -
    STEP, Inc., also served as the STEP plan sponsor from the
    plan’s inception until April 1, 1992.       U.S. Trust served as the
    successor plan sponsor from April 1, 1992, until February 14,
    1997, when first STEP, Inc., and subsequently Teplitzky & Co.
    took over as successor plan sponsor.       On February 7, 2002,
    Teplitzky & Co. resigned as plan sponsor and appointed SPSI as
    the successor plan sponsor.
    During the subject years, Teplitzky & Co., acting as the
    STEP plan administrator, ran the daily operation of the STEP
    plan.     U.S. Trust, as plan sponsor, interacted with the insurance
    companies whose policies were owned by the STEP plan and
    conducted the plan’s marketing activities.
    D.     Marketing Documents
    The STEP plan marketing documents set forth detailed
    examples of when severance benefits would and would not be paid
    under the plan.7    These examples allowed individuals covered by
    the plan to time their departures from their businesses and to
    phrase their requests for severance benefits so that benefits
    would be paid to them under the STEP plan as they anticipated.
    The STEP plan marketing documents warned participants that
    “Benefits accrued for an employee are forfeited if the employee
    does not qualify for benefits under a bona fide severance as
    7
    Upon adopting the plan, each participating employer also
    was provided examples of qualifying severance events.
    - 15 -
    determined by STEP’s Independent Fiduciary”.8   The STEP plan
    marketing documents advised participating employers that
    deductions for contributions to the STEP plan could be ultimately
    disallowed but that only taxes and interest, and no additional
    amounts such as penalties, would then be due because STEP had
    received an “opinion letter” from Mr. Mamorsky stating that it
    was “more likely than not” that the deductions would be allowed.
    E.   Independent Fiduciary
    The STEP plan administrator had the sole authority to make
    determinations relating to “dismissal”, “Total Disability”, or
    “death”, conditions that were prerequisites to the receipt of
    benefits from the STEP plan as written.   In making those
    determinations, the plan administrator was required to rely on
    rules and regulations established by the STEP plan “Independent
    Fiduciary”.   Jules Pagano (Mr. Pagano) was the independent
    fiduciary of the STEP plan from its inception through February
    2002; the STEP plan did not have any independent fiduciary
    thereafter.   While serving as independent fiduciary, Mr. Pagano
    was authorized to and routinely did provide individuals seeking
    to obtain benefits under the plan with personal guidance on how
    to frame their requests so that they would receive their
    anticipated benefits under the plan as written.   Upon receiving
    8
    In operation, however, forfeitures could occur only when
    projected plan assets equaled or exceeded projected plan
    liabilities on an employer by employer basis.
    - 16 -
    an actual claim for benefits, Mr. Pagano and the STEP plan
    administrator relied upon the documents submitted to them by the
    claimant and did not perform an independent investigation or
    verification of the claim.   If a participant’s claim for benefits
    as submitted did not qualify for benefits under the STEP plan,
    the STEP plan allowed the participant to reform his or her claim
    in order to receive his or her anticipated benefits.
    F.   Version 4 of the STEP Plan9
    Section 1.11, 1.13, and 1.14 of the STEP plan defines the
    terms “Covered Employee”, “Eligible Employee”, and “Employee”.
    Section 2.1(c) states that “The Employer shall transmit to the
    Plan Administrator written notice of any substantial or unusual
    change in a Covered Employee’s Compensation or status (e.g., from
    fulltime to parttime) as it occurs, but in any event no later
    than 30 days after the change occurs”.   Section 3.1 states that
    “A Covered Employee’s Severance Benefit shall be determined in
    accordance with the Severance Benefit formula elected in the
    Adoption Agreement.   In no event, however, may a Covered
    Employee’s Severance Benefit exceed two times his Compensation
    paid during the twelve full-month period immediately preceding
    his Termination of Employment”.
    9
    In our findings of fact set forth under this subheading,
    section references are to version 4 of the STEP plan.
    - 17 -
    Section 3.3 states that an employer shall elect in the
    adoption agreement either a “fixed benefit” or a “flexible
    benefit”.   As to a fixed benefit, section 3.3 states that the
    benefit payable to a covered employee shall equal the sum of the
    future service component for each year of participation plus the
    past service component.   The future service component equals for
    each year of participation the amount of that year’s
    “Compensation [defined as the “amount specified by the Employer
    in the Adoption Agreement”] multiplied by the Severance Benefit
    percentage elected by the Employer in the Adoption Agreement”.
    The past service component equals the product of (1) the benefit
    percentage elected by the employer in the adoption agreement,
    (2) a fraction not to exceed 1, the numerator of which is the
    covered employee’s past service and the denominator of which is
    10, and (3) the covered employee’s total compensation for the
    10 years preceding the year of termination of employment.
    As to a flexible benefit, section 3.3 allows a different
    percent of compensation to be elected for each year of service
    and states that the formula for computing a severance benefit is
    made applicable to the employer’s contribution each year.     In
    addition, there is a provision for adjustments each year based on
    benefits provided to other employees, forfeitures, investment
    earnings, and cost of insurance for the covered employee.
    - 18 -
    Section 4.1 states that the employer must annually
    contribute to the STEP plan such amounts as are calculated by the
    plan actuary to provide for severance benefits of its covered
    employees.     The total amount to be contributed by all employers
    is “based upon reasonable actuarial assumptions and methods
    taking into account the experience of the Plan, as an undivided
    and unweighted pool with no differentiation as to Covered
    Employees (other than those differentiations described below) or
    Participating Employers”.     The amount to be contributed by each
    employer is to be its allocable portion of the total for all
    employers.10    Section 4.1 also states that the employer must
    contribute the cost of 1-year term life insurance for any life
    insurance benefit elected in the adoption agreement.
    Section 5.2(a) states that a participating employer must pay
    the STEP plan the annual cost of equivalent 1-year term insurance
    if the employer elects a life insurance benefit for its
    employees.     Section 5.2(b) states that an employee may elect
    additional life insurance beyond the amount elected by the
    employer and that the employer must pay the STEP plan the annual
    cost of the equivalent 1-year term insurance and the employee
    must reimburse the employer for the additional cost.     Section
    5.2(c) states that the insurance benefit payable to the
    10
    In operation, the STEP plan neither employed a plan
    actuary nor determined amounts to be contributed by the
    employers.
    - 19 -
    beneficiary of a covered employee is equal to the amount elected
    by the employer plus the amount elected by the employee.    Section
    5.2(f) states that the STEP plan may name the beneficiary, or the
    insured may name a beneficiary as long as the employer reimburses
    the STEP plan.   Section 5.2(g) states that if the employer does
    not pay amounts due on the policy for the death benefit, STEP may
    declare the policy lapsed or surrender the policy, or the
    beneficiary will be changed to STEP.   Section 5.2(h) states that
    if the employer fails to make required payments, the insured may
    buy the policy from STEP for the policy value.
    Section 10.4(a) states that an employer can withdraw from
    the STEP plan at any time and that the employees will have frozen
    benefits equal to the amounts they would have been eligible for
    on the dates of withdrawal.   Section 10.5 states that if an
    employer fails to make a required contribution, it will be
    treated as if it withdrew on that date, and it will be treated
    the same as in the case of a withdrawal under section 10.4.
    Section 11.1 and 11.3 allows the plan sponsor to “amend,
    modify or delete, in whole or in part, any provision of the Plan,
    provided the duties and responsibilities of the Trustee shall not
    be altered without its written consent” and states that “no
    amendment or reorganization may be made to this Plan which shall
    change or alter the fundamental purpose of the Plan expressed in
    the preface hereto”.   Section 11.2 allows the plan sponsor to
    - 20 -
    reorganize the participating employers into other or separate
    plans.
    V.   VRD/RTD’s Introduction to the STEP Plan
    A.   Introduction to the Plan
    In late 1993, Drs. DeAngelis and Domingo were engaged in
    estate planning with their accountant, Richard Freeman (Mr.
    Freeman), and an estate planning attorney, Victor Finmann (Mr.
    Finmann).    Mr. Freeman advised Dr. DeAngelis to acquire
    additional life insurance coverage and suggested that he consider
    a severance pay plan for VRD/RTD.     Mr. Freeman introduced Dr.
    DeAngelis to Mr. Rapp.    Mr. Rapp discussed the STEP plan with Dr.
    DeAngelis and Mr. Freeman, characterizing the plan as a way to
    receive additional insurance coverage and to provide severance
    benefits, both with pretax dollars.     Mr. Rapp recommended to Dr.
    DeAngelis that VRD/RTD form a section 419 welfare benefit trust
    because, he stated, it would secure immediate Federal income tax
    deductions, allow the owner-employees to accumulate significant
    wealth on a tax-deferred basis, secure assets with insurance
    company guaranties, and protect assets from creditors.      Dr.
    DeAngelis discussed the STEP plan with the other doctors, their
    wives, Mr. Finmann, and others.    Mr. Finmann advised Dr.
    DeAngelis that he was skeptical as to the validity of the STEP
    plan, as promoted.
    - 21 -
    B.   Decision to Join Plan
    On December 20, 1993, Dr. DeAngelis decided on behalf of
    VRD/RTD to join the STEP plan and to provide coverage thereunder
    for the participating doctors and for Ms. Quinn.   Dr. Borrero
    declined to participate in the STEP plan after hearing the
    presentation of the representatives of STEP.   Dr. Capizzi
    initially expressed an intent to participate in the STEP plan but
    subsequently decided not to participate in the plan.
    C.   Illustrations
    In or about late 1993, Mr. Rapp provided Drs. DeAngelis and
    Domingo with life insurance policy illustrations reflecting
    varying amounts of life insurance benefits and premium costs.
    Mr. Rapp informed Dr. Domingo that his projected severance
    benefit after 5 years would be $253,000 if he made two annual
    contributions of $225,000 and that the projected benefit would
    increase annually by approximately $238,000 for each additional
    $225,000 contribution that he made annually beginning in year 3.
    Mr. Rapp informed Dr. DeAngelis that his projected severance
    benefit after 3 years would be $312,000 if he made two annual
    contributions of $300,000 and that the projected benefit would
    increase by approximately $320,000 for each additional $300,000
    contribution that he made annually beginning in year 3.
    - 22 -
    VI.   VRD/RTD’s Adoption of the STEP Plan
    A.   Execution of Adoption Agreement
    On or about December 20, 1993, Dr. DeAngelis executed an
    adoption agreement for the STEP plan on behalf of VRD/RTD, making
    VRD/RTD a participating employer in the STEP plan effective as of
    January 1, 1993.    VRD/RTD consented in the agreement to any
    future amendment of the STEP plan.
    VRD/RTD elected in the adoption agreement to provide
    severance benefits to its eligible employees in the amount of 10
    percent of an employee’s compensation for each year of
    participation, with no credit for past service.    VRD/RTD also
    elected not to provide the optional life insurance benefit.     Drs.
    DeAngelis and Domingo understood that in order for VRD/RTD to
    claim deductions for its contributions to STEP they had to couch
    any subsequent application for benefits in terms that appeared to
    make the severance event nonvolitional.
    B.   Relevant Provisions in the Adoption Agreement
    Eligible employees were defined in the adoption agreement as
    all full-time employees, other than controlling owners, who were
    21 and had completed 1 year of service and whose job title was
    “doctor” or “office administrator/business mgr”.    A “controlling
    owner” was defined in the adoption agreement as a person who
    owned more than a 25-percent voting interest in the participating
    employer, unless four or fewer other persons owned in the
    - 23 -
    aggregate a greater voting interest than the person.    The
    adoption agreement stated that the eligible employees were Drs.
    DeAngelis, Domingo, Durante, and Capizzi, and Ms. Quinn, and that
    Dr. Borrero was an employee who was excluded.11    The adoption
    agreement defined the term “compensation” as “Total Compensation
    paid during the applicable period, including wages, bonuses and
    over time [sic], etc., but not including deferred compensation
    other than compensation deferred pursuant to Code Section 401(k).
    Compensation shall also include salary reduction contributions
    excludable from gross income pursuant to Code Section 125.”
    C.   Other Relevant Provisions
    According to the STEP plan, a covered employee was
    purportedly eligible to receive a severance benefit from the plan
    upon termination of employment (except for termination for cause)
    under the following circumstances:     “dismissal; any termination
    of employment unless such termination constitutes a ‘voluntary
    separation without good cause’ within the meaning of New York
    State Unemployment Insurance Law; total disability; or death.12
    The STEP plan stated that benefits would normally start on the
    first day of the second month after approval of the claim for
    11
    As noted above, Dr. Capizzi subsequently decided not to
    participate in the STEP plan. Ms. Quinn was the only employee of
    VRD/RTD who was covered by the STEP plan.
    12
    In operation, the STEP plan paid benefits to participants
    even though the covered employee did not fall within one of these
    circumstances.
    - 24 -
    benefits, that the usual form of payment would be in equal
    monthly installments over 24 months from the date of the
    employee’s termination, that the first installment would include
    any payments delayed because of processing, and that severance
    benefits could not exceed two times the employee’s last 12 months
    of compensation before termination of employment.   The STEP plan
    did not limit the amount of life insurance benefits that could be
    received by a covered employee and stated that the optional life
    insurance benefit (if elected) would be received in addition to
    the severance benefit if the covered employee died while employed
    by the participating employer.   The STEP plan stated that a
    participating employer could choose to withdraw from the plan,
    that a participating employer could constructively withdraw from
    the plan by failing to make an annual contribution or by
    violating a plan provision, and that upon withdrawal, any
    optional life insurance benefit could be discontinued or
    purchased from the plan by the employee or alternate insured at a
    cost equal to the policy’s value (defined as the amount that
    would be paid upon surrender of the coverage determined before
    the application of surrender charges).   The STEP plan stated that
    the optional life insurance benefit also could be discontinued if
    the covered employee terminated service with the employer, the
    employer failed to make a contribution with respect to the
    coverage, or the covered employee ceased to be a covered
    - 25 -
    employee.    According to the STEP plan, any life insurance that
    was not purchased could be surrendered by the trustee or
    continued with the plan as beneficiary.
    VII.   VRD/RTD’s Contributions to STEP
    A.   Forwarding Fees
    The PCs of the participating doctors forwarded to VRD/RTD
    amounts required by STEP to pay the premiums due on the whole
    life insurance policies written on the lives of the participating
    doctors.     The PCs and VRD/RTD referred to these transactions as
    “forwarding fees”.      During the subject years, VRD/RTD received
    the following amounts of forwarding fees from the PCs:
    PC                        1993       1994
    Vincent R. DeAngelis M.D.P.C.       $300,000   $300,000
    Rodolfo T. Domingo M.D.P.C.          225,000    225,000
    Keith Durante M.D.P.C.                50,000     50,000
    Total                              575,000    575,000
    The PCs deducted these forwarding fees as expenses in the year of
    payment.
    VRD/RTD recorded its receipt of the forwarding fees from the
    PCs as “Fee Income--DeAngelis PC”, “Fee Income–-Domingo PC”, and
    “Fee Income–-Durante PC”, respectively.      VRD/RTD recorded that
    these amounts were received from the PCs as pension contributions
    with respect to the participating doctors.      VRD/RTD also received
    a total of $10,000 in each of the years 1993 and 1994, from the
    five PCs that were partners in VRD/RTD.      The $10,000 was
    forwarded in each year to the STEP plan to pay the premium due on
    - 26 -
    the policy insuring the life of Ms. Quinn.    Of the $10,000, Dr.
    Capizzi’s PC paid $2,400 in 1993 and $2,000 in 1994.     The record
    does not allow the Court to find the portion of the $10,000 in
    either year that was paid by any of the other PC partners.
    During each of 1993 and 1994, VRD/RTD contributed $585,000
    to the STEP plan and recorded each of these contributions as a
    “Pension Contribution”.   VRD/RTD’s partnership return reported
    the forwarding fees received from the PCs as income and claimed a
    corresponding deduction for “Retirement plans, etc.”     VRD/RTD did
    not make any further contribution to STEP, and neither STEP nor
    any petitioner directly paid any further premium on the subject
    life insurance policies after the premiums were paid on
    December 28, 1994, for the policy year beginning on that date.
    B.   Issuance of Policies
    When VRD/RTD adopted the STEP plan, all of VRD/RTD’s
    contribution to the plan was invested in whole life insurance
    policies issued by MetLife and sold by Mr. Rapp.    The particular
    policies were selected by the participating doctors in
    consultation with Mr. Rapp.   All of the policies were
    participating whole life insurance polices, with the additional
    feature that extra premiums could be paid to purchase paid-up
    additions rider insurance (PUAR).     A PUAR feature, when elected,
    essentially prefunds the annual premiums for a policy and
    - 27 -
    accumulates any extra proceeds in the policy until needed to pay
    premiums in a later year.
    As of December 28, 1993, MetLife issued the following six
    life insurance policies with respect to VRD/RTD’s initial
    contribution to the STEP plan:
    Insured            Policy #        Type of Policy     Face Value
    Dr. DeAngelis       931250799PR    Whole life            $2,156,442
    Both DeAngelises    931250800A     Survivor whole life    4,818,200
    Dr. Domingo         931250797PR    Whole life             1,327,656
    Both Domingos       931250798A     Survivor whole life    3,500,000
    Dr. Durante         931250795PR    Whole life             1,804,135
    Ms. Quinn           931250796PR    Whole life               409,184
    Four of these policies were individual whole life insurance
    policies separately insuring the lives of Ms. Quinn and each of
    the participating doctors.   The other two policies were joint and
    survivor whole life insurance policies (survivor whole life
    policies) or, in other words, life insurance that was not payable
    to the beneficiary until the deaths of both insureds.      One
    survivor whole life policy insured both DeAngelises (DeAngelises
    survivor whole life policy), and the other survivor whole life
    policy insured both Domingos (Domingos survivor whole life
    policy).   Neither Jeanette DeAngelis nor Bernadette Domingo was
    an employee of VRD/RTD, and the survivor whole life insurance
    policies were purchased by Drs. DeAngelis and Domingo as part of
    their Federal estate tax plans.     On December 28, 1993, Dr.
    DeAngelis was 60 years old, Jeanette DeAngelis was 61 years old,
    and each of the Domingos was 61 years old.      Also on that date,
    Dr. Durante was 37 years old, and Ms. Quinn was 38 years old.
    - 28 -
    Dr. DeAngelis canceled other life insurance that he personally
    owned so that insurance on the lives of him and his wife could be
    purchased through the STEP plan with pretax dollars.
    The initial owner of each of the six policies was U.S.
    Trust, as trustee of the STEP plan.        When U.S. Trust was replaced
    as trustee, the successor trustee was listed as owner.            As
    further discussed below, in 2001 STEP transferred to the Domingos
    ownership of the two policies written on the lives of one or both
    of them; in 2002, STEP transferred to Dr. DeAngelis ownership of
    the policy written on his life; and in 2003, STEP transferred
    ownership of each of the remaining policies to the insured or
    insureds named on the policy.
    The insured doctors designated the beneficiaries for their
    policies, and Ms. Quinn designated the beneficiaries for her
    policy; the STEP plan trustee was never listed as a beneficiary
    of any of the policies.     The beneficiaries of the subject
    policies were:
    Insured                  Beneficiary
    Dr. DeAngelis        DeAngelis Family Limited Partnership1
    Both DeAngelises     DeAngelis Family Irrevocable Life Insurance Trust
    Dr. Domingo          Domingo Family Irrevocable Life Insurance Trust
    Both Domingos        Domingo Family Irrevocable Life Insurance Trust
    Dr. Durante          Kathleen Durante
    Ms. Quinn            Mother, 2 sisters, and 3 brothers
    1
    The original beneficiary was Dr. DeAngelis’s wife.
    On or about Sept. 6, 2002, MetLife changed the beneficiary
    to the DeAngelis Family Limited Partnership pursuant to
    the request of Dr. DeAngelis.
    Mr. Rapp recommended that the beneficiary of each of the survivor
    whole life policies be listed as an insurance trust in order to
    - 29 -
    minimize the Federal estate tax consequences to the family of the
    insured, and Drs. DeAngelis and Domingo followed that
    recommendation.       STEP wanted any life insurance benefit to be
    paid directly to the personal beneficiary of the insured, rather
    than to or through the STEP plan, because STEP did not want the
    STEP plan to be overfunded if and when it were to receive that
    benefit.
    Two annual premiums were paid on each of the six policies,
    one for the policy year beginning December 28, 1993, and the
    other for the policy year beginning December 28, 1994.                     As to
    each policy, those premiums included the base premiums necessary
    to fund the whole life insurance component of the policy and
    premiums for PUAR.       These payments were consistent with
    illustrated payments contained in correspondence from Mr. Rapp.
    The base premiums and PUAR premiums on the policies were as
    follows:
    Insured            Policy #        Base Premium         PUAR       Total
    Dr. DeAngelis         931250799PR      $81,596.64    $98,403.36     $180,000
    Both DeAngelises      931250800A       103,762.66     16,237.34      120,000
    Dr. Domingo           931250797PR       53,093.13     52,656.87      105,750
    Both Domingos         931250798A        77,845.00     42,155.00      120,000
    Dr. Durante           931250795PR       21,996.32     28,003.68       50,000
    Ms. Quinn             931250796PR        6,173.67      5,826.33       12,000
    Total                                                              587,750
    Premiums were paid in the 2 years as follows:
    Insured                  Policy #              1993            1994
    Dr. DeAngelis            931250799PR        $180,000            $178,625
    Both DeAngelises         931250800A          120,000             120,000
    Dr. Domingo              931250797PR         105,750             104,375
    Both Domingos            931250798A          120,000             120,000
    - 30 -
    Dr. Durante              931250795PR      50,000     50,000
    Ms. Quinn                931250796PR      12,000     12,000
    Total1                                 587,750    585,000
    1
    We recognize that VRD/RTD deducted for 1993
    contributions totaling $585,000. In that the premiums paid
    in 1993 totaled $587,750, we are unable to find in the record
    an explanation as to who paid the extra $2,750.
    The funds used to pay the premiums attributable to the two
    policies written on the lives of one or both of the DeAngelises
    came from Dr. DeAngelis’s PC, the funds used to pay the premiums
    attributable to the two policies written on the lives of one or
    both of the Domingos came from Dr. Domingo’s PC, and the funds
    used to pay the premiums for the policy written on the life of
    Dr. Durante (Dr. Durante policy) came from his PC.       The funds
    used to pay the premiums attributable to the policy written on
    the life of Ms. Quinn (Ms. Quinn policy) were taken on some
    apportioned basis from all five PCs that were partners in
    VRD/RTD.13       In each of those cases, the funds used to pay the
    premiums went from each PC to VRD/RTD, from VRD/RTD to the STEP
    plan, and from the STEP plan to MetLife.
    C.   Additional Correspondence
    On September 19, 1995, Mr. Katz provided Mr. Freeman with
    revised illustrations for the life insurance policies written
    with respect to Drs. DeAngelis and Domingo.       Those illustrations
    13
    As discussed above, the record does not allow the Court
    to find the specifics of that apportionment other than as to Dr.
    Capizzi’s PC.
    - 31 -
    had been requested by Drs. DeAngelis and Domingo to help them
    determine whether they wanted to make any additional
    contributions on their policies.        The illustrations assumed that
    premiums were paid for only 3 years, 4 years, or 5 years.        Mr.
    Katz informed Mr. Freeman that the projected severance benefits
    for Drs. DeAngelis and Domingo were approximately the cash values
    in their policies.     Mr. Katz informed Mr. Freeman that he was
    formulating illustrations for the policies that would show a cash
    withdrawal of severance benefits and the premium required to
    continue the policies thereafter.        On September 20, 1995, Mr.
    Rapp provided Drs. DeAngelis and Domingo with answers from
    MetLife and STEP to questions asked by those doctors.
    On or about October 30, 1995, Mr. Katz provided Dr.
    DeAngelis with revised illustrations for his insurance policies
    showing only 2 years of out-of-pocket premium payments.        Mr. Katz
    also provided Mr. Freeman with various other illustrations for
    the insurance policies written on the lives of Drs. DeAngelis and
    Domingo.
    VIII.     Payments of Premiums
    A.   Dr. DeAngelis Policy
    The December 28, 1993 and 1994, premiums of $81,596.64 on
    the policy written on the single life of Dr. DeAngelis (Dr.
    - 32 -
    DeAngelis policy) were paid timely,14 and PUAR was purchased with
    additional premiums of $98,403.36 in 1993 and $97,028.36 in 1994.
    In 1996, the premium due on this policy as of December 28, 1995,
    was paid timely with a dividend withdrawal of $16,658.17 and a
    portion of a withdrawal of $123,004.98 from the PUAR.15    As to
    the withdrawal from the PUAR, $64,938.47 was used to pay the
    December 28, 1995, premium on this policy, and $58,066.51 was
    used to pay the December 28, 1995, premium on the DeAngelises
    survivor whole life policy.    In 1997, the premium due on December
    28, 1996, on the Dr. DeAngelis policy was paid timely with a
    dividend withdrawal of $15,247.77 and a withdrawal of $66,348.87
    from the PUAR.    The premium due on December 28, 1997, was not
    paid timely, and the policy lapsed for nonpayment of premiums.
    MetLife converted the policy to nonforfeiture extended term
    insurance with a face value of $2,192,891 through August 21,
    2000, at which time it was set to be depleted of its cash value
    and thus to terminate without value.16
    14
    Although the premiums were not actually paid until after
    the due dates, we consider them to have been paid “timely”. To
    this end, we understand each of the subject insurance policies to
    have allowed a grace period after the due date so that a premium
    paid during that period would be timely in the sense that the
    policy would not lapse.
    15
    A dividend withdrawal relates to a dividend payable on a
    policy.
    16
    Extended term insurance is a life insurance policy
    nonforfeiture option that may be exercised when the policy lapses
    (continued...)
    - 33 -
    B.   DeAngelises Survivor Whole Life Policy
    The December 28, 1993 and 1994, premiums of $103,762.66 on
    the DeAngelises survivor whole life policy were paid timely, and
    PUAR was purchased in each year with additional premiums of
    $16,237.34.   In 1996, the premium due on December 28, 1995, was
    paid timely with a dividend withdrawal of $11,563.68, a
    withdrawal of $34,133.47 from the PUAR, and the above-referenced
    $58,066.51 withdrawal from the Dr. DeAngelis policy.   In 1997,
    the premium due on December 28, 1996, was paid with a dividend
    withdrawal of $12,363 and a policy loan of $91,399.66.    The
    premium due on December 28, 1997, was not paid timely, and the
    policy lapsed for nonpayment of the premium.   MetLife converted
    the policy to participating reduced paid-up insurance with a face
    value of $588,731.17
    On or about August 23, 1999, upon the request of Dr.
    DeAngelis (and in connection with a similar request of Dr.
    16
    (...continued)
    because of a failure to pay a premium owed on the policy. Under
    this option, the cash value of a lapsed policy is used to
    maintain the full original death benefit until the cash value is
    depleted.
    17
    A reduced paid-up feature is another life insurance
    policy nonforfeiture option that may be exercised when the policy
    lapses because of a failure to pay a premium owed on the policy.
    If such a feature is exercised, the remaining cash value of the
    policy is used to purchase a single premium life insurance policy
    with a lower death benefit. While the death benefit is reduced,
    the cash value in the policy is used up more slowly than under
    other nonforfeiture options.
    - 34 -
    Domingo with respect to the Domingos survivor whole life policy),
    the DeAngelises survivor whole life policy was reinstated by
    MetLife to the full face value and converted retroactively to a
    policy with an automatic premium loan (APL) provision.18   That
    feature was then applied to pay the premiums of $103,762.66 due
    on December 28, 1997 and 1998, through an APL of $207,525.32.
    MetLife’s stated reason for reinstating the DeAngelises survivor
    whole life policy was that the policy had lapsed because of
    “company error”; specifically, MetLife stated, Dr. DeAngelis
    wanted loans to be made automatically from the policy to pay the
    premiums and was not advised by the broker that the policy was
    set up with a nonforfeiture option of reduced paid-up insurance.
    The DeAngelises survivor whole life policy lapsed again after the
    nonpayment of the premium due on December 28, 1999 (the cash
    value in the policy was insufficient to support an APL), and in
    October 2000 was converted to participating reduced paid-up
    insurance with a face value of $669,547.
    18
    APL provisions allow an insurance company to pay a
    premium due on a policy by way of a loan taken out against the
    cash value of the policy. The loan is subject to interest
    charges and affects the policy’s cash value only as a potential
    reduction of that value. The total amount of outstanding loans
    on the policy is usually less than the policy’s cash value
    because the policy will generally lapse when the total amount of
    the loans exceeds that cash value.
    - 35 -
    C.   Dr. Domingo Policy
    The December 28, 1993 and 1994, premiums of $53,093.13 on
    the policy written on the single life of Dr. Domingo (Dr. Domingo
    policy) were paid timely, and PUAR was purchased with additional
    premiums of $52,656.87 in 1993 and $51,281.87 in 1994.     In 1996,
    the premium due on December 28, 1995, was paid timely with a
    dividend withdrawal of $10,358.01 and a withdrawal of $42,735.12
    from the PUAR.   In 1997, the premium due on December 28, 1996,
    was paid timely with a dividend withdrawal of $10,416.38 and a
    withdrawal of $42,676.75 from the PUAR.     The premium due on
    December 28, 1997, was not paid timely, and the policy lapsed for
    nonpayment of the premium.     MetLife continued the policy as
    nonparticipating paid-up term insurance with a face value of
    $1,377,206 through December 1, 2000, at which time it was set to
    be depleted of its cash value and thus to terminate without
    value.
    D.   Domingos Survivor Whole Life Policy
    The December 28, 1993 and 1994, premiums of $77,845 on the
    Domingos survivor whole life policy were paid timely, and PUAR
    was purchased in each year with additional premiums of $42,155.
    In 1996, the premium due on December 28, 1995, was paid timely
    with a dividend withdrawal of $8,960 and a withdrawal of $68,885
    from the PUAR.   In 1997, the premium due on December 28, 1996,
    was paid timely with a dividend withdrawal of $9,616, a
    - 36 -
    withdrawal of $21,407 from the PUAR, and a policy loan of
    $46,820.   The premium due on December 28, 1997, was not paid
    timely, and the policy lapsed for nonpayment of the premium.
    MetLife converted the policy to reduced paid-up insurance with a
    face value of $511,542.
    On or about October 19, 1999, upon the request of Dr.
    Domingo (and in connection with the above-referenced similar
    request of Dr. DeAngelis), the Domingos survivor whole life
    policy was reinstated by MetLife to the full face value and
    converted retroactively to a policy with an APL provision.    That
    feature was then applied to pay the premiums of $77,845 due on
    December 28, 1997 and 1998, through an APL of $155,690.
    MetLife’s stated reason for reinstating the Domingos survivor
    whole life policy in 1999 was that the policy had lapsed because
    of “company error”; specifically, MetLife stated, Dr. Domingo
    wanted loans to be made automatically from the policy to pay
    premiums and was not advised by the broker that the policy was
    set up with a nonforfeiture option of reduced paid-up insurance.
    The Domingos survivor whole life policy lapsed again after the
    nonpayment of the premium due on December 28, 1999 (the cash
    value in the policy was insufficient to support an APL), and in
    2000 was converted to participating reduced paid-up insurance
    with a face value of $579,263.
    - 37 -
    E.    Dr. Durante Policy
    The December 28, 1993 and 1994, premiums of $21,996.32 on
    the Dr. Durante policy were paid timely, and PUAR was purchased
    in each year with additional premiums of $28,003.68.      In 1996,
    the premium due on December 28, 1995, was paid timely with a
    dividend withdrawal of $1,881.58 and a withdrawal of $20,114.74
    from the PUAR.     In 1997, the premium due on December 28, 1996,
    was paid timely with a dividend withdrawal of $1,618.17 and a
    withdrawal of $20,378.15 from the PUAR.      The premium due on
    December 28, 1997, was not paid timely, and the policy lapsed for
    nonpayment of the premium.      MetLife continued the policy as
    nonparticipating paid-up term insurance with a face value of
    $1,864,269 through February 1, 2005, at which time it was set to
    be depleted of its cash value and thus to terminate without
    value.
    F.     Ms. Quinn Policy
    The December 28, 1993 and 1994, premiums of $6,173.67 on the
    Ms. Quinn policy were paid timely, and PUAR was purchased in each
    year with additional premiums of $5,826.33.      In 1996, the premium
    due on December 28, 1995, was paid timely with a dividend
    withdrawal of $422.06 and a withdrawal of $5,751.61 from the
    PUAR.     In 1997, the premium due on December 28, 1996, was paid
    timely with a dividend withdrawal of $337.18 and a withdrawal of
    $5,836.49 from the PUAR.       The premium due on December 28, 1997,
    - 38 -
    was not paid timely, and the policy lapsed for nonpayment of the
    premium.   MetLife continued the policy as nonparticipating paid-
    up term insurance with a face value of $410,881 through May 7,
    2003, at which time it was set to be depleted of its cash value
    and thus to terminate without value.
    IX.   Dispute of Drs. DeAngelis and Domingo
    In 1999, Dr. DeAngelis received a statement from STEP
    showing that the death benefit for the DeAngelises survivor whole
    life policy had decreased by approximately $3.5 million.   The
    statement caused Dr. DeAngelis to write letters to STEP,
    Teplitzky & Co., and Mr. Rapp, requesting an explanation for the
    decrease in value.   Dr. DeAngelis (and ultimately Dr. Domingo)
    also retained an attorney as to this matter.
    On investigation, Dr. DeAngelis concluded that the policies
    had lapsed for nonpayment of premiums, contrary to the advice
    that he had received at the inception of his participation in
    STEP that the policies would be self-sustaining after the making
    of the first two contributions.   Because the option on each
    policy to pay the annual premiums through an APL had not been
    elected on the insurance application form, each of the six
    subject policies lapsed as of the end of 1997.
    The failure to make the APL election on the insurance
    application forms was partially that of Mr. Rapp, who
    misunderstood the expressed intent of Drs. DeAngelis and Domingo
    - 39 -
    that the APL election be made on their policies.        After the lapse
    of the policies, much correspondence on the subject ensued
    between Drs. DeAngelis and Domingo and their lawyer, on the one
    hand, and MetLife, Mr. Rapp, and/or Teplitzky & Co., among
    others, on the other hand, and Drs. DeAngelis and Domingo
    threatened to file a lawsuit as to the matter.        Drs. DeAngelis
    and Domingo sought from MetLife the reinstatement of their and
    Ms. Quinn’s single individual policies as reduced paid-up
    insurance retroactively to the original lapse date.
    X.   Reinstatement of Policies
    A.   Overview
    On January 24, 2002, Marcia McDermott (Ms. McDermott), an
    internal consultant for MetLife, asked MetLife to reinstate the
    lapsed policies of Dr. DeAngelis and Ms. Quinn as paid-up
    insurance retroactively to the original lapse date, as if the
    policies had never lapsed.      Previously, Ms. McDermott had made a
    similar request as to the Dr. Domingo policy.        Because Dr.
    Durante did not ask Ms. McDermott to seek a similar reinstatement
    of the Dr. Durante policy, Ms. McDermott did not ask MetLife to
    reinstate the Dr. Durante policy.
    B.   Dr. Domingo Policy
    STEP transferred ownership of the Dr. Domingo policy to Dr.
    Domingo in or about November 2001.        Although the policy
    technically had no value, Dr. Domingo wanted the policy because
    - 40 -
    Ms. McDermott had agreed to reinstate the policy as a reduced
    paid-up policy retroactive to December 28, 1997.     Subsequently,
    pursuant to the request of Dr. Domingo, MetLife changed the Dr.
    Domingo policy to reduced paid-up insurance retroactively
    effective to December 28, 1997, with a face value of $195,924.
    MetLife stated in part that it was making this change because
    neither Dr. Domingo nor the STEP plan trustee had received timely
    notice of either the lapse of the policy or multidistrict
    litigation involving MetLife’s marketing practices; the trustee
    had directed MetLife to send all mail to the trustee in care of
    the STEP plan administrator.     Following this change, the Dr.
    Domingo policy has continued as participating reduced paid-up
    insurance.
    From December 28, 1993, through the present, Dr. Domingo
    received life insurance coverage of $195,924 to $1,377,206
    through the Dr. Domingo policy.     As of December 28, 2005, the
    policy’s death benefit and net cash surrender value were
    $267,034.57 and $185,025.58, respectively.
    C.   Dr. DeAngelis Policy
    On or about January 24, 2002, the ownership of the Dr.
    DeAngelis policy was changed to his name.     Shortly thereafter,
    the Dr. DeAngelis policy was changed from nonforfeiture extended
    term insurance to participating reduced paid-up insurance
    retroactively effective to December 28, 1997, with a face value
    - 41 -
    of $264,809.   MetLife stated in part that it was making this
    change because neither Dr. DeAngelis nor the STEP plan trustee
    had received timely notice of either the lapse of the policy or
    multidistrict litigation involving MetLife’s marketing practices;
    the trustee had directed MetLife to send all mail to the trustee
    in care of the STEP plan administrator.    Before the formal change
    of ownership, Dr. DeAngelis understood that the policy
    technically had no value but that MetLife was going to change the
    policy to reduced paid-up status retroactively to 1997.    As of
    December 28, 2004 and 2005, respectively, the Dr. DeAngelis
    policy had a death benefit of $349,286 and $360,559.21 and a net
    cash surrender value of $232,215.81 and $244,798.07.
    D.   Ms. Quinn Policy
    On January 3, 2003, Dr. DeAngelis formally terminated
    VRD/RTD’s participation in STEP.    At that time, Dr. DeAngelis
    offered on behalf of VRD/RTD to purchase from the STEP plan the
    DeAngelises survivor whole life policy, the Dr. Durante policy,
    and the Ms. Quinn policy.    Dr. DeAngelis offered to purchase
    these policies at a cost of 10 percent of each policy’s cash
    value, payable as a withdrawal from the policy’s cash value.
    On July 28, 2003, STEP assigned the ownership of the Ms.
    Quinn policy to Ms. Quinn.    No severance event had occurred under
    the STEP plan to permit this assignment.    In connection with the
    assignment, Ms. Quinn executed a claim settlement and release
    - 42 -
    form, backdated to January 3, 2003, the day of VRD/RTD’s formal
    termination of its participation in the STEP plan.
    On August 7, 2003, STEP informed Ms. Quinn that it had asked
    MetLife to change the ownership of the Ms. Quinn policy from the
    STEP trustee to Ms. Quinn and that any action to reinstate the
    policy had to be made by Ms. Quinn.      One day later, MetLife
    informed SPSI that it had received STEP’s request to change the
    ownership of the Ms. Quinn policy but MetLife’s records indicated
    that the policy had expired and was no longer in force.      At the
    request of Dr. DeAngelis, the Ms. Quinn policy was changed by
    MetLife later in 2003 to reduced paid-up insurance retroactively
    effective to December 28, 1997, with a face value of $34,135.      On
    September 30, 2003, MetLife confirmed to Ms. Quinn that she was
    the owner of the Ms. Quinn policy and that the policy was being
    continued as reduced paid-up insurance in the amount of $34,135,
    which would increase as dividends were credited to the policy.
    On or after January 16, 2004, Ms. Quinn surrendered the Ms.
    Quinn policy to MetLife and received a check from MetLife in the
    amount of $15,573.69.   MetLife processed the check on January 27,
    2004.   From December 28, 1993, through January 16, 2005, Ms.
    Quinn received life insurance coverage of $34,135 to $410,881
    through the Ms. Quinn policy.
    - 43 -
    XI.   Survivor Whole Life Policies
    A.   Domingos Survivor Whole Life Policy
    On December 10, 2001, STEP assigned the ownership of the
    Domingos survivor whole life policy to Dr. Domingo.    As of
    December 28, 2001, the Domingos survivor whole life policy had a
    total death benefit of $596,009.81, less an outstanding policy
    loan of $220,206.85, for a net death benefit of $375,802.96.      As
    of the same date, the Domingos survivor whole life policy had a
    cash surrender value of $224,475.17, less the outstanding policy
    loan of $220,206.85, for a net cash surrender value of $4,268.32.
    As of November 2006, the Domingos survivor whole life policy had
    a cash value base of $277,316.37, a cash value of additional
    insurance of $21,380.58, an existing loan of $279,056.26, and
    loan interest due of $13,793.75, for a net cash surrender value
    of $5,846.94.    From December 28, 1993, through the present, the
    Domingos received life insurance coverage of between $511,542 and
    $3,500,000 through the Domingos survivor whole life policy.
    B.   DeAngelises Survivor Whole Life Policy
    On July 28, 2003, STEP assigned the ownership of the
    DeAngelises survivor whole life policy to the DeAngelises.     No
    severance event had occurred under the STEP plan to permit this
    assignment.    In connection with the assignment, Dr. DeAngelis
    also executed a claim settlement and release form backdated to
    January 3, 2003.
    - 44 -
    As of various times, the policy’s death benefit and net cash
    surrender value were as follows:
    As of            Death Benefit   Net Cash Surrender Value
    3/1/1999          $595,195.38          $186,974.68
    12/28/1999         4,663,784.34           220,495.10
    12/28/2000           678,528.13           236,229.57
    12/28/2001           688,464.08           253,038.08
    2/5/2003           699,316.63           272,153.06
    3/31/2003           669,547.00           274,537.72
    12/28/2004           713,391.54           305,930.83
    12/28/2005           719,830.71           324,053.39
    XII.    Dr. Durante Policy
    As of March 1, 1999, the cash surrender value of the Dr.
    Durante policy was $52,982.52.      As of December 31, 2001, the cash
    surrender value of the policy was $23,508.43.      As of February 25,
    2003, the cash surrender value of the Dr. Durante policy was
    $21,811.95.       As of each of these dates, the death benefit payable
    under the policy was $1,864,269.
    On July 28, 2003, STEP assigned the ownership of the Dr.
    Durante policy to Dr. Durante.      No severance event had occurred
    under the STEP plan to permit this assignment.      In connection
    with the assignment, Dr. Durante also executed a claim settlement
    and release form backdated to January 3, 2003.
    On August 4, 2003, the cash surrender value of the Dr.
    Durante policy was $17,635.98, and the death benefit was
    $1,864,269.       The Dr. Durante policy had no value once it expired
    on February 1, 2005.      From December 28, 1993, through February 1,
    - 45 -
    2005, Dr. Durante received life insurance coverage of $1,804,135
    to $1,864,269 through the Dr. Durante policy.
    XIII.     Acquisition of STEP
    STEP was acquired from Teplitzky & Co. in February 2002 by
    STEP Acquisition Group, Inc.        Afterwards, SPSI offered
    participants three options.        Option A was “To continue
    participation in the STEP Plan & Trust as the Plan is now and as
    it is amended from time to time.”        Option B was “To terminate our
    participation in the STEP Plan & Trust and to have 80% of the
    potential severance benefit paid out to each of our employees
    over a 24 month period.”        Option C was “To terminate our
    participation in the STEP Plan and rollover 90% of the potential
    severance benefit to purchase new insurance policies to provide
    death benefit protection in the BENISTAR 419 Plan and Trust.”
    The STEP plan does not provide for any of these options.         On June
    28, 2002, Dr. DeAngelis signed a STEP “Option Selection Form”
    stating that VRD/RTD had decided “To continue participation in
    the STEP Plan & Trust as the Plan is now and as it is amended
    from time to time.”
    XIV.     Recordkeeping for the STEP Plan
    STEP maintained its records of employer contributions;
    insurance policy premiums; potential severance benefits; policy
    values; termination, surrender, or withdrawal dates; forfeitures;
    severance payments; “frozen” potential severance benefits; and
    - 46 -
    surrenders and withdrawals on an employee-by-employee basis
    within each employer group, further segregated by each of the
    eight insurance companies participating in the STEP plan.    STEP
    maintained its books and records first by insurance company,
    second by employer group, and finally by each individual
    employee.   Forms 5500-C/R, Return/Report of Employee Benefit
    Plan, filed by the STEP plan were generally broken down by
    insurance company, employer group, and employee.   Forms W-2, Wage
    and Tax Statement, were issued to participants with separate
    employer identification numbers for each life insurance company.
    Each insurance policy was essentially a separate account for
    the covered employee on whose life the policy was written.     The
    account included all of the employer’s contributions for that
    employee, was increased by all of the income earned as a result
    of those contributions, was reduced by all insurance company
    charges to provide the life insurance benefits for only that
    employee, and was used as the base from which to calculate the
    purported severance benefits of that employee.   A severance
    benefit that was paid out to an employee was typically not equal
    to what had been paid in by way of employer contributions.     The
    employer contribution was invested by STEP, and the assets grew.
    VRD/RTD’s contributions were invested in the individual
    insurance policies of the participating doctors and Ms. Quinn.
    The contributions for each policy were accounted for separately.
    - 47 -
    Dividends were credited to the policy, and insurance charges were
    taken out of each of the policies to pay for the cost of
    providing the covered employee with life insurance coverage.
    STEP applied a factor to the cash value of the life insurance
    policy on the covered employee’s life in order to compute the
    benefit payable to the employee.   The insurance policies (or the
    cash derived therefrom) were distributed to VRD/RTD’s
    participating employees without regard to STEP’s purported
    computation of the allowable amounts of severance benefits.
    XV.   Dr. Domingo’s Receipt of Plan Benefits
    On April 3, 1997, Dr. Domingo wrote to Mr. Katz requesting a
    “legal opinionated [sic] letter” regarding his “intent to retire
    within the time period of 3 years” for “business reasons and for
    continuity of our surgical group.”     Dr. Domingo requested that
    any response be sent to him “Personal and Confidential.”     Mr.
    Katz relayed Dr. Domingo’s letter to Mr. Pagano.     On May 1, 1997,
    Mr. Pagano advised Dr. Domingo that he would receive full
    benefits under the STEP criteria of “good cause” and “genuine
    business purpose” if he resigned after being asked to retire.
    Mr. Pagano advised Dr. Domingo that he would not qualify for
    benefits if he agreed to work for VRD/RTD in a different
    capacity.
    On March 21, 2001, Dr. Domingo informed Teplitzky & Co. that
    on January 1, 1999, he “retired completely from my surgical
    - 48 -
    practice” and wanted to know about the severance monetary
    benefits available to him.   On March 28, 2001, Teplitzky & Co.
    informed Dr. Domingo that he needed to establish a severance
    event in order to qualify for benefits under the plan and had to
    establish to the satisfaction of the plan’s independent fiduciary
    that the termination was for good cause within the meaning of New
    York State Unemployment Insurance Law.   Teplitzky & Co. enclosed
    examples of “good cause” under New York law and advised Dr.
    Domingo to call Mr. Mamorsky if he had any questions.
    On June 17, 2001, Dr. Domingo relayed to the STEP plan
    administrator his revised request for severance benefits,
    including a formal “Request for Benefit Payments” and an attached
    “Reason for Termination of Service”.   The revised claim removed
    all reference to his prior statement that he had “completely
    retired” from his surgical practice.   The revised claim stated
    that on October 5, 1998, VRD/RTD asked him to terminate his
    association with the group effective January 1, 1999, because his
    financial contribution to the group was not satisfactory.     Dr.
    Domingo claimed that his compensation for the last 12-month
    period before his termination of service was $323,334.
    On July 16, 2001, VRD/RTD mailed to Teplitzky & Co. an
    “Employer Request for Payment of Benefits” for Dr. Domingo
    listing the date of severance as January 1, 1999, and stating
    that the compensation paid to Dr. Domingo for the last 12-month
    - 49 -
    period before termination of employment was $323,334.   Attached
    to the request was the same “Reason for Termination of Service”
    that Dr. Domingo had attached to his benefit request.   Both forms
    were signed by Dr. DeAngelis on June 30, 2001.   Before that
    request, neither VRD/RTD nor Dr. Domingo notified STEP that Dr.
    Domingo had stopped providing services to VRD/RTD on January 1,
    1999.
    On August 10, 2001, Teplitzky & Co. forwarded Dr. Domingo’s
    claim for severance benefits to Mr. Pagano, asking Mr. Pagano if
    he agreed or disagreed with the claim.   On September 4, 2001, Mr.
    Pagano informed Teplitzky & Co. that he had reviewed Dr.
    Domingo’s claim for severance benefits and that he confirmed that
    it was an “induced termination due to non renewal of contract”
    which would be a qualifying event for severance benefits under
    the STEP plan.
    On September 20, 2001, Teplitzky & Co. notified Dr. Domingo
    that his severance benefit had been approved in the estimated
    amount of $233,661 and offered Dr. Domingo the opportunity to
    “purchase” the Domingos survivor whole life policy, coverage of
    which was $587,232, for $5,496.   On September 25, 2001, Dr.
    Domingo wrote to Teplitzky & Co. asking for answers to certain
    questions he had about his benefits and his life insurance
    policies, including a question as to why he had to pay so much to
    purchase the Domingos survivor whole life policy.   On September
    - 50 -
    28, 2001, Teplitzky & Co. responded to Dr. Domingo’s questions,
    indicating, among other things, that the purchase price for his
    policy was determined by subtracting from the $217,305 cash
    surrender value of the policy the maximum loan that could be
    taken of $211,809, leaving a balance in the policy of $5,496.     On
    October 9, 2001, Ms. McDermott confirmed in writing to Dr.
    Domingo that MetLife would be willing to change the policy on his
    life to reduced paid-up status retroactively effective to the
    date when a request to make such a change could have been timely
    made.   Ms. McDermott also informed Dr. Domingo that the policy
    was still “technically an asset of the severance plan” so it
    would be a “good idea” to get the policy from the plan before the
    change was made.   Ms. McDermott attached a letter showing that
    the policy is presently of “no value to the plan” to assist Dr.
    Domingo in getting the policy.
    On October 14, 2001, Dr. Domingo advised Teplitzky & Co.
    that he wished to purchase the Domingos survivor whole life
    policy.   One day later, Dr. Domingo sent to Mellon Trust a $2,000
    check from Rodolfo T. Domingo M.D.P.C. and a $3,496 check from
    the Domingo Family Limited Partnership as requested by the STEP
    plan administrator to purchase the Domingos survivor whole life
    policy.   On October 24, 2001, Teplitzky & Co. applied for a
    policy loan on and requested a change in ownership of the
    Domingos survivor whole life policy.   The policy loan was used to
    - 51 -
    pay to Dr. Domingo his requested severance benefits totaling
    approximately $220,000.
    XVI.    Dr. DeAngelis’s Receipt of Plan Benefits
    Dr. DeAngelis filed a claim for severance benefits with STEP
    in November 2002.        In connection therewith, Dr. DeAngelis on
    November 19, 2002, signed a “Request for Payment of Benefits”
    stating that he was terminating his services because of “prostate
    cancer, with symptoms which interfere with employee’s ability to
    perform surgery” and that his compensation for the 12-month
    period before his termination of service was approximately
    $350,000.     Dr. DeAngelis underwent radiation and incurred
    radiation colitis to try to treat his prostate cancer and
    continued to work until December 31, 2003.
    Wayne Bursey (Mr. Bursey), the president of SPSI, approved
    the claim.        Mr. Bursey was concerned about the possibility of
    future litigation between Dr. DeAngelis and STEP, insofar as Drs.
    DeAngelis and Domingo had threatened suit against the prior plan
    administrator but had never instituted any such litigation.
    OPINION
    I.     Overview
    We are faced once again with an issue arising from a plan
    designed aggressively to bolster the sale of insurance products
    through a claim of permissible tax savings.        Cf. Neonatology
    Associates, P.A. v. Commissioner, 
    115 T.C. 43
    , 99 (2000), affd.
    - 52 -
    
    299 F.3d 221
    (3d Cir. 2002).   Respondent determined that neither
    the PCs’ payments to VRD/RTD related to the STEP plan nor
    VRD/RTD’s ensuing contributions to the STEP plan were deductible
    under section 162(a) as ordinary and necessary business expenses
    and that the amounts of the payments were includable in the
    doctors’ gross income under section 61(a).     Respondent argues
    that the payments were made for the doctors’ personal benefit.
    Petitioners argue that the payments and contributions are
    deductible under section 1.162-10(a), Income Tax Regs., as
    “Amounts paid or accrued within the taxable year for dismissal
    wages” and, thus, that the payments are not includable in the
    doctors’ gross income.   We agree with respondent’s determination
    on the disallowed deductions but disagree with respondent’s
    determination on the inclusion in income.     We set forth our
    analysis below primarily in two sections.     The first section sets
    forth our opinion of the credibility of the witnesses.       The
    second section sets forth our opinion on the substantive issues
    at hand.
    II.   Credibility of the Witnesses
    A.   Expert Witnesses
    At trial, each party called an expert witness in support of
    their and his respective positions.     Petitioners called
    Michael L. Frank (Mr. Frank), and the Court recognized him as an
    expert on experience rating and risk sharing.     Mr. Frank is an
    - 53 -
    actuary who graduated from the University of Michigan in 1987 and
    has worked in the insurance industry ever since.    He currently
    works for his own company in part (1) advising employers on the
    purchase of insurance, (2) consulting on employee benefits and
    the plans related thereto, (3) brokering and underwriting
    insurance, and (4) helping insurance and other companies
    underwrite insurance.   His credentials include that he is
    licensed to sell life and other forms of insurance in 18 States,
    that he is an associate of the Society of Actuaries, that he is a
    member of the American Academy of Actuaries, and that he is a
    fellow of the Conference of Consulting Actuaries.    Petitioners
    retained him less than 3 months before trial to testify as an
    expert in this proceeding.   Mr. Carpenter, with whom Mr. Frank
    has had a longstanding working and personal relationship,
    recommended him.
    Respondent called Charles C. DeWeese (Mr. DeWeese) at trial
    to testify as an expert, and the Court recognized Mr. DeWeese as
    an expert on multiple-employer benefit plans, insurance
    experience rating, and individual life insurance policies.    Mr.
    DeWeese is an independent consulting actuary who graduated from
    Yale University in 1968 and has worked in the insurance industry
    ever since.   His credentials include that he has been a fellow of
    the Society of Actuaries since 1972, a member of the American
    Academy of Actuaries since 1974, and a fellow of the Conference
    - 54 -
    of Consulting Actuaries since 1987.     Various courts, including
    this one, have previously recognized Mr. DeWeese as an expert on
    subjects similar to those relevant herein, and he has repeatedly
    testified as an expert on those subjects, including twice in this
    Court.    See Neonatology Associates, P.A. v. 
    Commissioner, supra
    at 85-86; Booth v. Commissioner, 
    108 T.C. 524
    , 573 (1997).
    The Court has broad discretion to evaluate the cogency of an
    expert’s analysis.    See Neonatology Associates, P.A. v.
    
    Commissioner, supra
    at 85.    Sometimes, an expert will help us
    decide a case.    See, e.g., id.; Booth v. 
    Commissioner, supra
    at
    573; Trans City Life Ins. Co. v. Commissioner, 
    106 T.C. 274
    , 302
    (1996).    Other times, he or she will not.   See, e.g., Estate of
    Scanlan v. Commissioner, T.C. Memo. 1996-331, affd. without
    published opinion 
    116 F.3d 1476
    (5th Cir. 1997); Mandelbaum v.
    Commissioner, T.C. Memo. 1995-255, affd. without published
    opinion 
    91 F.3d 124
    (3d Cir. 1996).     Aided by our common sense
    and our perception of the expert during his or her testimony, we
    weigh the helpfulness and persuasiveness of an expert’s testimony
    in the light of his or her qualifications and with due regard to
    all other credible evidence in the record.     See Neonatology
    Associates, P.A. v. 
    Commissioner, supra
    at 84-85.     We may embrace
    or reject an expert’s opinion in toto, or we may pick and choose
    the portions of the opinion to adopt.     See Helvering v. Natl.
    Grocery Co., 
    304 U.S. 282
    , 294-295 (1938); IT&S of Iowa, Inc. v.
    - 55 -
    Commissioner, 
    97 T.C. 496
    , 508 (1991).     We are not bound by an
    expert’s opinion and will reject an expert’s opinion to the
    extent that it is contrary to the judgment we form on the basis
    of our understanding of the record as a whole.    See IT&S of Iowa,
    Inc. v. 
    Commissioner, supra
    at 508.
    In making our findings of fact and reaching our decisions
    herein, we have given little weight to the testimony of Mr.
    Frank.   Although the Court recognized Mr. Frank as an expert on
    the stated subjects, we were and remain troubled that Mr. Frank
    has a longstanding and continuing working and personal
    relationship with Mr. Carpenter and other entities and persons
    with financial and/or other direct interests in the resolution of
    these cases.   See Neonatology Associates, P.A. v. Commissioner,
    
    115 T.C. 86
    (stating that “An expert witness loses his or her
    impartiality when he or she is too closely connected with one of
    the parties” and holding that such an expert is of limited value
    to the Court).   In fact, during trial, we were forced to admonish
    Mr. Frank that he should not be improperly communicating with one
    or more of the just-referenced persons and petitioners’ counsel.
    In addition to that stated relationship, we also on the basis of
    our observation of Mr. Frank’s candor, sincerity, and demeanor
    perceived him to be of little help to the Court in deciding these
    cases.   As to Mr. DeWeese, we have respected his testimony and
    given that testimony appropriate weight.    When Mr. DeWeese
    - 56 -
    previously testified before this Court, the Court on each
    occasion found him to be reliable, relevant, and helpful on the
    areas that were the subject of his expertise.   See
    id. at 85-86;
    Booth v. 
    Commissioner, supra
    at 573.   We find him likewise
    helpful in these cases.
    B.   Fact Witnesses
    At trial, petitioners called five witnesses to testify as to
    the facts of these cases; respondent called three such witnesses.
    Petitioners’ fact witnesses were Drs. DeAngelis and Domingo and
    Messrs. Mamorsky, Bursey, and Teplitzky.   Respondent’s fact
    witnesses were Dr. Borrero, Mr. Mamorsky, and Ms. McDermott.19
    On the basis of our perception of the witnesses and our review of
    the record as a whole, we do not find much of the testimony of
    the fact witnesses to be helpful as to the critical facts
    underlying the issues at hand.   See generally Neonatology
    19
    For completeness, we note that respondent also called Mr.
    Carpenter to testify at an evidentiary hearing held immediately
    before trial. Petitioners had moved the Court approximately 1
    month before trial to issue an order generally disqualifying Mr.
    DeWeese from testifying as an expert witness in this proceeding
    and had attached to their motion an affidavit of Mr. Carpenter
    setting forth serious allegations questioning the objectivity of
    Mr. DeWeese. In respondent’s response to that motion (as
    supplemented by petitioners to address in part a question by the
    Court as to why petitioners had not filed their motion earlier),
    respondent raised serious issues of truthfulness on the part of
    Mr. Carpenter and requested in part that the Court hold an
    evidentiary hearing so that respondent could question Mr.
    Carpenter as to his actions connected with this proceeding and
    the subject matter thereof. The Court granted respondent’s
    request. The Court ultimately denied petitioners’ motion as
    supplemented.
    - 57 -
    Associates, P.A. v. 
    Commissioner, supra
    at 84 (discussing the
    standards that the Court applies to evaluate the testimony of
    trial witnesses).     We rely mainly on the testimony of Mr. DeWeese
    and the voluminous record built by the parties through their
    comprehensive stipulation of facts and exhibits.
    III.    Substantive Issues at Hand
    A.   Disallowance of Deductions
    Section 162(a) generally provides that “There shall be
    allowed as a deduction all the ordinary and necessary expenses
    paid or incurred during the taxable year in carrying on any trade
    or business”.     A taxpayer such as VRD/RTD or one of the PCs must
    meet five requirements in order to deduct an item under this
    section.     The taxpayer must prove that the item claimed as a
    deductible business expense:     (1) Was paid or incurred during the
    taxable year; (2) was for carrying on its trade or business;
    (3) was an expense; (4) was a necessary expense; and (5) was an
    ordinary expense.20    See Commissioner v. Lincoln Sav. & Loan
    Association, 
    403 U.S. 345
    , 352 (1971); Welch v. Helvering,
    
    290 U.S. 111
    , 115 (1933); see also Rule 142(a)(1).     A
    determination of whether an expenditure satisfies each of these
    20
    While sec. 7491(a) places the burden of proof upon the
    Commissioner in certain cases, the Court has decided in an
    unpublished order that sec. 7491(a) has no applicability to these
    cases.
    - 58 -
    requirements is a question of fact.    See Commissioner v.
    Heininger, 
    320 U.S. 467
    , 475 (1943).
    Petitioners argue that section 162(a) allowed VRD/RTD and
    the PCs to deduct the amounts related to the STEP plan because
    those amounts represented “dismissal wages” paid to a “welfare or
    similar benefit plan” within the scope of section 1.162-10(a),
    Income Tax Regs.   We disagree.   While the STEP plan may have been
    cleverly designed to appear to be a welfare benefits fund and
    marketed as such, the facts of these cases establish that the
    plan was nothing more than a subterfuge through which the
    participating doctors, through VRD/RTD, used surplus cash of the
    PCs to purchase cash-laden whole life insurance policies
    primarily for the benefit of the participating doctors
    personally.   While employers are not generally prohibited from
    funding term life insurance for their employees and deducting the
    premiums on that insurance as a business expense under section
    162(a), employees are not allowed to disguise their investments
    in life insurance as deductible benefit-plan expenses when those
    investments accumulate cash value for the employees personally.
    See Neonatology Associates, P.A. v. 
    Commissioner, supra
    at 88-89.
    The insurance premiums at hand pertained to the
    participating doctors’ personal investments in whole life
    insurance policies that primarily accumulated cash value for
    those doctors personally.   VRD/RTD’s contributions to the STEP
    - 59 -
    plan were used to pay the initial year’s cost of providing life
    insurance for each participating doctor and to create an
    investment fund for the insured within his whole life insurance
    policy (or policies in the cases of Drs. DeAngelis and Domingo).
    That fund, when enhanced with expected future dividends, was
    calculated to be sufficient to pay for the future years’ costs of
    life insurance protection and to provide for cash values
    sufficient to allow for a distribution of cash to the insured
    doctor whenever he opted to claim that he was involuntarily
    terminated from his business.    As to each investment fund (and as
    to each insurance policy in general), the insured doctor regarded
    that fund (and policy) as his own, as did the STEP plan trustee,
    the STEP plan administrator, and MetLife.   Very little (if any)
    value in one participating doctor’s fund was available to pay to
    another insured, and any distribution of cash from the STEP plan
    to a participating doctor was directly related to the cash value
    of his policy.   In many instances, a participating doctor dealt
    with his own insurance agent in selecting and purchasing the
    policy on his life, received illustrations on an assortment of
    life insurance investments that could be made through the STEP
    plan, determined the amount of his investment in his life
    insurance policy, selected the form of the insurance policy to be
    issued for him (e.g., single whole life versus survivor whole
    life), and selected his policy’s face amount.   In the latter
    - 60 -
    regard, we note our finding on the basis of the credible evidence
    in the record that Drs. DeAngelis and Domingo, when dealing with
    Mr. Rapp, MetLife, and the insurance policies in general, were
    not acting as agents of VRD/RTD but were acting in their
    individual capacities.   We also note our finding that Dr. Durante
    was not acting as an agent of VRD/RTD with respect to his policy.
    The use of whole life insurance policies and the direct
    interactions between the participating doctors and the STEP plan
    representatives support our finding that the participating
    doctors in their individual capacities fully expected to get
    their promised benefits and that any receipt of those benefits
    was not considered by anyone connected with the life insurance
    transaction to rest on any unexpected or contingent event.     Each
    whole life insurance policy upon its issuance was in and of
    itself a separate account of the insured doctor, and the insured
    (rather than the STEP plan) dictated and directed the funding and
    management of the account and bore most risks incidental to the
    account’s performance.   The STEP plan in essence and in operation
    was simply an aggregation of separate plans for the participating
    doctors and not, as petitioners claim, one single plan in which
    various employers participated.   The cash value in a
    participating doctor’s policy was both intended to be and
    actually returned to the insured doctor, net of reductions for
    the cost of current insurance coverage and other de minimis
    - 61 -
    amounts that were payable for charges related to the policies or
    otherwise incidental to the participation in the STEP plan.    In
    fact, upon learning that their policies had lost the value that
    they expected to receive, Drs. DeAngelis and Domingo pursued
    recovery of those losses both directly and aggressively with
    their insurance agent and with the STEP plan representatives and
    caused the policies written on their lives to be transferred to
    them (and the Ms. Quinn policy to be transferred to her) as they
    had expected from the start of their investment in the STEP plan.
    As to the DeAngelises survivor whole life policy and the Domingos
    survivor whole life policy, the retroactive reinstatement and
    conversion of those policies to APL also rebuts petitioners’
    claim that each insurance policy was truly an asset of the STEP
    plan which the plan had the unfettered right to benefit from, to
    liquidate, or to dispose of; to the contrary, the cash value
    theoretically belonging to the STEP plan was converted into death
    benefits for Drs. DeAngelis and Domingo even though VRD/RTD had
    stopped making contributions years before the conversion.
    We also note the events leading up to the initial purchase
    of the whole life insurance policies.   Through the partnership
    agreement executed on June 19, 1990, Drs. DeAngelis and Domingo
    had expressed their intent to retire in the near future.    Yet, in
    connection with the planning of their personal estates and their
    consideration of ways to reduce the application to their estates
    - 62 -
    of the Federal estate tax, Dr. DeAngelis caused VRD/RTD to join
    the STEP plan on December 30, 1993.     Drs. DeAngelis and Domingo
    were told that their 1993 and 1994 payments to the STEP plan
    would suffice to fund the future costs of providing life
    insurance benefits for the remainder of their lives and to
    provide future distributions of cash to them at the time of their
    choosing.   From the beginning of their decision to participate in
    the STEP plan, the participating doctors were most concerned
    about the amounts of, and their ability to receive, their
    expected benefits from STEP.    In fact, Drs. DeAngelis and Domingo
    requested calculations and illustrations showing how much they
    would receive depending upon the number of years that
    contributions were made to the STEP plan.    Drs. DeAngelis and
    Domingo also wrote to Mr. Katz for assurance that they would
    receive their benefits and requested a written opinion from the
    plan sponsor about how to characterize their planned departures
    from their practices so as to meet the terms of the STEP plan as
    written.    STEP advised the participating doctors on what to say
    in order to get their promised benefits, and STEP assured the
    doctors that a protocol was in place to ensure that they would
    get their money as intended.    Because each of the participating
    doctors’ PCs funded its own employee’s benefits under the STEP
    - 63 -
    plan, STEP was at no significant loss in allowing each PC to
    remove from the plan the money it invested therein.21
    Petitioners rely erroneously on Booth v. Commissioner,
    
    108 T.C. 524
    (1997), in arguing that these cases turn primarily
    not on the application of section 162(a) but on the question of
    whether the STEP plan meets the requirements of section
    419A(f)(6).   As discussed herein, our decisions in these cases
    turn on our factual evaluation of the relationship between the
    participating doctors and their whole life insurance policies
    without any regard to the STEP plan’s qualification under section
    419A(f)(6), and we decide on the basis of the credible evidence
    in the record before us that those doctors upon investing in the
    STEP plan had the primary right to receive the value reflected in
    the insurance policies written on their lives.   We note in this
    regard that the Court in Booth v. 
    Commissioner, supra
    , did not
    decide the issue under section 162(a) that we decide today.
    In sum, we find that the PCs’ payments to VRD/RTD were
    distributions to the doctors personally and that neither those
    payments nor VRD/RTD’s ensuing contributions to STEP were
    ordinary and necessary business expenses under section 162(a)
    21
    We also are mindful that the provisions in the STEP plan
    were routinely not followed; e.g., Dr. Domingo received a
    “severance” benefit even though he informed the STEP plan
    administrator that he had “completely retired”, a situation that
    even the author of the STEP plan admitted was not an eligible
    event under the STEP plan as written.
    - 64 -
    (except to the extent they relate to payments of premiums on the
    Ms. Quinn policy as discussed supra note 3).        Accord Neonatology
    Associates, P.A. v. Commissioner, 
    115 T.C. 43
    (2000).
    Consequently, we hold that those amounts are not deductible under
    section 162(a) by either the PCs or VRD/RTD.22
    B.    Inclusion in Income
    Respondent determined that the amounts of the life insurance
    premiums that were paid by each doctor’s PC on his behalf are
    includable in the doctor’s gross income under section 61(a) as
    “accessions to wealth, clearly realized, and over which the
    taxpayers have complete dominion.”        See Commissioner v. Glenshaw
    Glass Co., 
    348 U.S. 426
    , 431 (1955).       We disagree that those
    amounts are includable in the doctors’ gross income.       While the
    payments of the premiums were indeed accessions to the doctors’
    wealth, our decision on this issue does not rest simply on that
    finding.    Instead, our decision turns on our finding that the
    doctors’ PCs were S corporations and that the payment of the
    premiums by the PCs was essentially a distribution to the doctors
    of corporate profits rather than a payment that the PCs made to
    the doctors with a compensatory intent.       See Neonatology
    22
    Although the PCs may arguably be entitled to deduct the
    costs of the current life insurance protection purchased through
    the STEP plan, see Neonatology Associates, P.A. v. Commissioner,
    
    115 T.C. 43
    (2000), petitioners have not requested any such
    deductions, and the record does not allow the Court to find the
    amounts of any such deductions.
    - 65 -
    Associates, P.A. v. 
    Commissioner, supra
    at 91-92, 95-96; see also
    Neonatology Associates, P.A. v. 
    Commissioner, 299 F.3d at 231-232
    .   In accordance with the Federal income tax law
    applicable to S corporations, most particularly sections 1367 and
    1368, our disallowance of the deductions claimed by the PCs has
    the effect of increasing pro tanto the net income of those PCs,
    with corresponding increases to the doctors’ distributive shares
    of that income.   That being so, the payments of the premiums are
    not taxed a second time to the doctors.23   Cf. Neonatology
    Associates, P.A. v. Commissioner, 
    115 T.C. 95-96
    (tax at the
    shareholder-level was appropriate where the employer was a C
    corporation).
    We have considered each argument made by petitioners for
    holdings contrary to those expressed herein and have rejected all
    arguments not discussed herein as irrelevant or without merit.
    We also have considered each argument made by respondent for a
    holding contrary to that expressed herein as to the inclusion in
    23
    In other words, we regard each distribution as a tax-free
    recovery of adjusted basis, taking into account the increase in
    basis resulting from the disallowance of deductions claimed by
    the PC.
    - 66 -
    income and have rejected all arguments not discussed herein as
    irrelevant or without merit.   Accordingly,
    Decisions will be entered
    under Rule 155.